GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LabTurbo Biotech Corp (ROCO:7725) » Definitions » Cash Conversion Cycle

LabTurbo Biotech (ROCO:7725) Cash Conversion Cycle : 524.28 (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is LabTurbo Biotech Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

LabTurbo Biotech's Days Sales Outstanding for the six months ended in Jun. 2024 was 47.17.
LabTurbo Biotech's Days Inventory for the six months ended in Jun. 2024 was 551.
LabTurbo Biotech's Days Payable for the six months ended in Jun. 2024 was 73.89.
Therefore, LabTurbo Biotech's Cash Conversion Cycle (CCC) for the six months ended in Jun. 2024 was 524.28.


LabTurbo Biotech Cash Conversion Cycle Historical Data

The historical data trend for LabTurbo Biotech's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LabTurbo Biotech Cash Conversion Cycle Chart

LabTurbo Biotech Annual Data
Trend Dec21 Dec22 Dec23
Cash Conversion Cycle
124.95 99.34 290.70

LabTurbo Biotech Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash Conversion Cycle Get a 7-Day Free Trial 58.96 167.03 181.74 604.02 524.28

Competitive Comparison of LabTurbo Biotech's Cash Conversion Cycle

For the Biotechnology subindustry, LabTurbo Biotech's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LabTurbo Biotech's Cash Conversion Cycle Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LabTurbo Biotech's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where LabTurbo Biotech's Cash Conversion Cycle falls into.



LabTurbo Biotech Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

LabTurbo Biotech's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=116.75+217.84-43.89
=290.70

LabTurbo Biotech's Cash Conversion Cycle for the quarter that ended in Jun. 2024 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=47.17+551-73.89
=524.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LabTurbo Biotech  (ROCO:7725) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


LabTurbo Biotech Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of LabTurbo Biotech's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


LabTurbo Biotech Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
3F-1, No. 150, Section 4, Chengde Road, Shilin District, Taipei, TWN
LabTurbo Biotech Corp is a company that is mainly engaged in the research and development, production, sales of nucleic acid extraction, genetic testing, genetic testing reagents, instruments, and the operation of sports science venues. Its main products and services include the entire process. Automated precision medical genetic testing systems and reagent kits as well as testing services.

LabTurbo Biotech Headlines

No Headlines